Advertisement

Gallopamil pp 123-131 | Cite as

Anti-anginal Effect of Gallopamil as Compared with Nifedipine

  • R. Hopf
  • H. Drews
  • M. Kaltenbach
Conference paper
  • 13 Downloads

Abstract

The introduction of calcium antagonists has considerably extended the potential drug treatments of angina pectoris. Given on their own (Freedman et al. 1980; Hopf et al. 1982) or in combination with organic nitrates (Raizner et al. 1981) and/or β-adrenergic blockers (Lessem 1981) calcium antagonists may afford an impressive increase of exercise tolerance in many patients. This holds for patients with stable angina pectoris as well as for patients in whom anginal symptoms may be triggered and possibly intensified by additional coronary spasms (Freedman et al. 1980; Maseri et al. 1975, 1978; Parodi et al. 1981; Raizner et al. 1981; Schulz et al. 1981).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Freedman B, Richmond DR, Kelly DT (1980) Coronary spasm management with Verapamil (Isoptin ®). Med J Aus 2: 22–25Google Scholar
  2. Hopf R, Becker H-J, Kober G, Dowinsky S, Kaltenbach M (1982) Therapie der Angina pectoris mit Calcium-Antagonisten. Herz 4: 221–234Google Scholar
  3. Lessem J (1981) Combined administration of Verapamil and Beta-blockers in patients with Angina pectoris. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil. Excerpta Medica, Amsterdam-Oxford-Princeton, p 159–166Google Scholar
  4. Maseri A, Mimmo R, Chierchia S, Marchesi C, Pesola A, L’Abbate A (1975) Coronary artery spasm as a cause of acute myocardial ischemia in man. Chest 68: 625–633CrossRefGoogle Scholar
  5. Maseri A, L’Abbate A, Marzilli M, Ballestra AM, Chierchia S, Parodi O, Severi S (1978) Coronary vasospasm as a cause of acute myocardial infarction: A conclusion suggested by the study of Preinfarction Angina. In: Kaltenbach M, Lichtlen P, Balcon R, Bussmann W-D (eds) Coronary heart disease, 3rd Int Symp Frankfurt Thieme, Stuttgart p 163–173Google Scholar
  6. Parodi O, L’Abbate A, Simonetti I, Severi S, Marzullo P, Trivella MG, Maseri A (1981) Verapamil in the treatment of vasospastic Angina pectoris. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil. Excerpta Medica, Amsterdam Oxford Princeton, p 176–184Google Scholar
  7. Raizner AE, Chahine RA, Gaston WR, Smith DL, Luchi RJ, Miller RR (1981) The effectiveness of combined Verapamil and Nitrate therapy in Prinzmetal’s Variant Angina. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil. Excerpta Medica, Amsterdam Oxford Princeton, p 191–197Google Scholar
  8. Schulz W, Krauss G, Kaltenbach M, Kober G (1981) Einfluß von intrakoronarem und intravenösem Nifedipin auf die allgemeine und lokale Gefäßweite von epikardialen Koronararterien bei stabiler Angina pectoris — ein antianginöser Wirkaspekt? Z Kardiol 70: 809–815Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • R. Hopf
  • H. Drews
  • M. Kaltenbach

There are no affiliations available

Personalised recommendations